To access the efficacy of Amalkyadi Kaphaghna Basti with Lekhaghna Basti in the treatment of Dyslipidemia

Phase 3

Not yet recruiting

• Conditions: Overweight and obesity. Ayurveda Condition: MEDOROGAH,

• Registration Number: CTRI/2024/02/062434
• Lead Sponsor: Mahatma Gandhi Ayurved College Hospital and Research Centre

Brief Summary

the Volunteers will be informed about protocol, welling participants will be randomly selected as per computer generated table. clinical research format will be prepared and validated. prior to the study approval will be taken from IEC and MGAC and RC Salod Hirapur Wardha. CTRI registration will be done after selection each participants will be tested individually and selected according to selection criteria. they are divided into 3 groups the trial is parallel group  randomized open table Standard Control trial. it will include 45 days treatment period and a follow up period on 15th, 30th, 45th day.

Detailed Description

Not available

Study Timeline

• Study Start: 2024-02-29
• Last Update Posted: 2024-05-02

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Patients who are willing to give Written Informed Cosent Clinical cases of Dyslipidemia as per 1CD 10 Criteria E78 point 5 diagnosed with either sex between the age group of 20 to 50 years Diagnosed and confirmed cases of Dyslipidemia according to National Cholesterol Education Program and Adult Treatment Panel 3 NCEP ATPIII 2001 as follows Total cholesterol less than or equal to 200 mg per dL and or LDL from 130 to 189 mg per dL and or Sr Triglycerides between 150 to 499 mg per dL and or Sr HDL more than 40mg per dL.

Exclusion Criteria

Patients who are not willing to give Written Informed Consent Patients with Unstable Angina myocardial infarction stroke transient ischemic attack cardiovascular surgery or major operations within 6 months prior to screening visit Patient having systemic illness like Tuberculosis Carcinoma Endocrine disorders and Renal or Liver disorder Drug induced Dyslipidemia like steroids etcPregnant Lactating women Patients with Ano-rectal disorders like Fissure Fistula Haemorrhoids etc Patients with Hypothyroidism Patients with NIDDM Patients with Hypertension.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To access the efficacy of Kaphaghna Basti in Lipid Profile	1 month 15 days

Secondary Outcome Measures

Name	Time	Method
To access the efficacy of Lekhana Basti in Lipid Profile	45 Days
To access the efficacy of Tab Atrovastatin 10 mg in Lipid Profile	45 Days

Trial Locations

Locations (1)

Mahatma Gandhi Ayurved College Hospital and Research Centre; 🇮🇳 Wardha, MAHARASHTRA, India

Mahatma Gandhi Ayurved College Hospital and Research Centre

🇮🇳Wardha, MAHARASHTRA, India

Dr Shamli Hiware

Principal investigator

7709793303

shamlihiware57@gmail.com